Insider buying last 90 days
No open-market insider purchases were filed for OHI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every OHI insider filing, plotted on the chart in Gekko.Open OHI in Gekko
Omega Healthcare Investors (OHI) Stock Analysis & Forecast
Sep 28 close
$46.68+0.40 (+0.9%)
Gekko Brief
AI summaryOmega Healthcare Investors was downgraded from buy to hold this week, with the move attributed to growth appearing fully priced in at current levels even as the company posted strong Q2 results and raised AFFO guidance. Separate coverage also compared OHI against DiamondRock Hospitality (DRH) on relative value grounds. The stock closed at $46.17 on 23 September before the downgrade commentary followed on 27 September.
OHI closed at $46.68, up 0.9%, sitting between its 50-day average of $47.70 and 200-day average of $46.47, a mixed trend picture. The GekkoIndex reads 61.4, placing the stock in the Accumulation zone. Price sits 26.6% below the Gekko Fair Value of $63.6, a gap that stands out against the recent analyst downgrade framing further upside as limited.
The next earnings date falls on 3 November 2026, 35 days out and beyond a typical 20-trading-day holding window; the prior report on 29 July beat estimates, with EPS of $0.83 against a $0.77 estimate, though shares reacted -2.4% at the time. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows. Seasonally, the next 20 trading days have averaged a 2.1% return over 5 years, rising in 2 of them, a pattern worth noting alongside the current 5-analyst hold-leaning split of 3 buy, 4 hold, and 2 sell ratings with a consensus target of $51.89.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Omega Healthcare Investors price vs fair value
Close $46.68200-day averageGekko Fair Value $63.60
Omega Healthcare Investors quick facts
- Market cap
- $13.96B
- P/E ratio
- 16.4
- Forward P/E
- 10.1
- EPS, TTM
- $2.82
- Revenue, TTM
- $1.26B
- Profit margin
- 68.1%
- Dividend yield
- 5.83%
- Beta
- 0.57
- Volume
- 1.66M avg 2.09M
- 1-year return
- +12.6%
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.1%
- 50-day average
- $47.70
- 200-day average
- $46.47
- Next earnings
- Nov 3
- Shares outstanding
- 299.1M
Omega Healthcare Investors swing-trade checklist
Omega Healthcare Investors scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendmixed
Averages disagree
Close $46.68 sits between the 50-day ($47.70) and 200-day ($46.47) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
61.4, Accumulation
Reading 61.4 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
26.6% below
Price is 26.6% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 35 days
Next report Nov 3, 2026, 35 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+2.1% on average
From this point in the calendar, the next 20 trading days averaged +2.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Omega Healthcare Investors stock chart and price history
Omega Healthcare Investors closed at $46.68 on Sep 28, 2026, +12.6% over the past year, inside a 52-week range of $39.26 to $52.39.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +0.8%
- 3 months
- −3.0%
- 6 months
- +4.8%
- 1 year
- +12.6%
The full OHI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open OHI in Gekko
Follow Omega Healthcare Investors through every session
Put OHI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track OHI in GekkoFree for 7 days. No credit card required.
About Omega Healthcare Investors
Omega Healthcare Investors operates as a real estate investment trust that puts its money into properties used for skilled nursing and assisted living care. Rather than running these facilities itself, it owns the buildings and works with a range of healthcare operators who take on the day-to-day management of the properties.
Most of its arrangements with these operators are structured as triple-net leases, meaning the tenants typically cover costs like taxes, insurance and maintenance on the properties they occupy. Its holdings stretch across every region of the United States, with additional properties located in the United Kingdom.
Omega Healthcare Investors trades under the ticker OHI.
- Sector
- Finance
- Website
- omegahealthcare.com
Omega Healthcare Investors GekkoIndex: the smart money zone
Omega Healthcare Investors’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61.4, in the Accumulation zone, up 0.2 points over five sessions.
61.4Accumulation
Up 0.2 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 10 | +1.6% | +4.9% | ||
| Accumulation (current zone) | 168 | +0.9% | +2.7% | ||
| Neutral | 423 | +0.2% | +0.9% | ||
| Distribution | 24 | −0.1% | +2.1% | ||
| Selling | 0 | Not available | |||
Average OHI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the OHI price, zone by zone.Track OHI in Gekko
Is Omega Healthcare Investors stock overvalued? Gekko Fair Value
Omega Healthcare Investors trades 26.6% below Gekko Fair Value of $63.60, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Omega Healthcare Investors shares are worth, recalculated every trading day.
$63.60
Gekko Fair Value, Sep 26, 2026
26.6% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open OHI in Gekko
Omega Healthcare Investors insider and Congress trading
No open-market insider purchases were filed for Omega Healthcare Investors, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in OHI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for OHI, plotted on the chart in Gekko.Open OHI in Gekko
Buybacks
Omega Healthcare Investors has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $13.28M
- As a share of market cap
- 0.10%
From company filings.
Omega Healthcare Investors earnings: next date and track record
Omega Healthcare Investors reports on Nov 3, 2026 (35 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 3, 2026
35 days away
- EPS estimate
- $0.47
- Revenue estimate
- $268.6M
6 of 8reports beat the EPS estimate
±3.1%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 29, 2026 AI summary
- What they said
- Omega Healthcare Investors reported Q2 2026 results with year-over-year revenue and AFFO growth, driven by new investments, annual escalators, and active portfolio management. Management highlighted a strong balance sheet, significant liquidity from asset sales and loan repayments, and improved operator coverage across the triple-net and SHOP portfolios. The company completed strategic dispositions (notably 18 CommuniCare assets) and proactively transitioned underperforming assets to higher-credit operators (Saber, HHC), which management expects to improve credit and yield future earnings accretion once proceeds are redeployed. Management emphasized a robust pipeline across skilled nursing, senior housing, and U.K. care homes, forecasting increased transaction volume later in 2026 and into 2027. They also noted operational improvements, hiring to expand data/AI, and an anticipated Genesis bankruptcy closing by year-end that will satisfy related loans. Leadership transitions were announced (Taylor Pickett and Bob Stephenson retiring) and management expressed confidence in the next executive team.
- Guidance
- - Expectation of meaningful increase in transaction dollar volume late 2026 into 2027 based on pending deals forecasted to close. - Anticipated Genesis bankruptcy closing by year-end with buyer assuming master lease and satisfaction of term and DIP loans. - Management indicated Q3 earnings headwind from $563M in asset sales (and some sales late in the quarter impacting Q3). - Mid-single-digit organic FAD growth target over time (management quantified about 6-7% annualized FAD growth as achievable). - No specific numerical quarterly or annual revenue/earnings guidance provided beyond these directional statements.
- Risks flagged
- - Ongoing Genesis bankruptcy and related credit exposure until closing. - Short-term headwind to sequential earnings/AFFO due to large asset dispositions and loan repayments. - Regulatory risk: increased focus by HHS/CMS on fraud and abuse could create indirect impacts or state budget constraints. - Potential state rate-setting changes in certain markets (a few negative outcomes noted) though not expected to materially impact coverage. - Operator performance variability (need to manage underperforming operators, watch-list risk), though coverage has improved.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.83 est $0.77 | $262.7M est $267.0M | −2.4% |
| Apr 28, 2026 | $0.48 est $0.49 | $266.9M est $264.1M | +0.1% |
| Feb 4, 2026 | $0.55 est $0.49 | — | +6.1% |
| Oct 30, 2025 | $0.79 est $0.77 | $311.6M est $287.2M | +6.3% |
| Oct 29, 2025 | $0.59 est $0.46 | $311.6M est $287.2M | −0.3% |
| Jul 31, 2025 | $0.77 est $0.75 | $282.5M est $247.9M | +2.9% |
| May 1, 2025 | $0.75 est $0.75 | $276.8M est $236.7M | −5.2% |
| Feb 5, 2025 | $0.74 est $0.41 | $279.3M est $226.2M | +1.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Omega Healthcare Investors stock forecast and analyst price targets
Analysts’ average 12-month price target for Omega Healthcare Investors is $51.89, +11.2% from the last close, from 9 firms rating the stock in the last 90 days.
$51.89consensus 12-month target, +11.2% from the last close
Now $46.68Avg $51.89
Low $46High $58
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 1 | Wells Fargo | $48 | +2.8% |
| Aug 31 | Mizuho Securities | $46 | −1.5% |
| Aug 31 | Barclays | $50 | +7.1% |
| Aug 21 | UBS | $54 | +15.7% |
| Aug 14 | Bank of America Securities | $49 | +5.0% |
+2.7%average 20-day move after past Accumulation readings
+2.1%average move over the next 20 trading days in the last 5 years
±1.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Omega Healthcare Investors seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Omega Healthcare Investors averaged +2.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.6% | 2 of 5 |
| Next 10 trading days | +0.5% | 3 of 5 |
| Next 15 trading days | +2.3% | 3 of 5 |
| Next 20 trading days | +2.1% | 2 of 5 |
| Next 30 trading days | +2.0% | 3 of 5 |
For scale, OHI’s typical 20-trading-day move in either direction is about 4.1%.
Omega Healthcare Investors market cap and key statistics
Omega Healthcare Investors’s market cap is $13.96B, with a P/E ratio of 16.4 and revenue of $1.26B over the last twelve months.
Valuation
- Market cap
- $13.96B
- P/E ratio
- 16.4
- Forward P/E
- 10.1
- EPS, TTM
- $2.82
- Gekko Fair Value
- $63.60
Trading
- Volume
- 1.66M
- Avg volume, 20 days
- 2.09M
- 52-week high
- $52.39
- 52-week low
- $39.26
- Shares outstanding
- 299.1M
Financials
- Revenue, TTM
- $1.26B
- Profit margin
- 68.1%
- Return on equity
- 16.5%
- Quarterly earnings growth, YoY
- +161.3%
Risk and income
- Beta
- 0.57
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 5.83%
Omega Healthcare Investors stock news this week
Coverage of Omega Healthcare Investors this week reads neutral: 0 positive, 2 neutral and 1 negative headlines.
- Omega Healthcare: Attractive For The Near 6% Yield, But Don't Expect Meaningful Upside (Rating Downgrade)Seeking Alpha, Sep 27
- Omega Healthcare Investors downgraded to hold as growth is fully priced and near-term upside is limited.Pluang, Sep 27
- Omega Healthcare Investors, Inc. (OHI) Stock Price, News, Quote & HistoryYahoo! Finance Canada, Sep 23
- DRH or OHI: Which Is the Better Value Stock Right Now?Zacks Investment Research, Sep 23
Omega Healthcare Investors stock FAQ
What is Omega Healthcare Investors’s market cap?
Omega Healthcare Investors’s market cap is $13.96B at the Sep 28, 2026 close of $46.68, with 299.1M shares outstanding. The shares trade on a P/E ratio of 16.4.
What is the Omega Healthcare Investors stock forecast?
The consensus analyst 12-month price target for Omega Healthcare Investors is $51.89, +11.2% from the last close. Of the 9 firms that rated the stock in the last 90 days, 3 rate it a buy, 4 a hold and 2 a sell. Gekko doesn’t publish price predictions of its own.
Is Omega Healthcare Investors stock overvalued or undervalued?
On Gekko’s estimate Omega Healthcare Investors is undervalued: the Sep 28, 2026 close of $46.68 is 26.6% below Gekko Fair Value of $63.60. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Omega Healthcare Investors report earnings next?
Omega Healthcare Investors is expected to report on Nov 3, 2026 (35 days away). Analysts expect earnings of $0.47 per share on revenue of $268.6M. Omega Healthcare Investors beat the earnings estimate in 6 of its last 8 reports, moving 3.1% on average across the report.
What is Omega Healthcare Investors’s 52-week high and low?
Omega Healthcare Investors’s 52-week high is $52.39 and its 52-week low is $39.26; it closed at $46.68 on Sep 28, 2026, +12.6% over the past year.
Is Omega Healthcare Investors stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Omega Healthcare Investors the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.